Novo Integrated Sciences, Inc. Quarterly Liabilities, Current in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Novo Integrated Sciences, Inc. quarterly Liabilities, Current history and growth rate from Q4 2010 to Q2 2024.
  • Novo Integrated Sciences, Inc. Liabilities, Current for the quarter ending May 31, 2024 was $22.7M, a 265% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $22.7M +$16.5M +265% May 31, 2024 10-Q 2024-07-19
Q1 2024 $9.96M +$3.78M +61.2% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 $10.9M -$1.65M -13.1% Nov 30, 2023 10-Q 2024-01-22
Q3 2023 $7.9M -$6.17M -43.8% Aug 31, 2023 10-Q 2024-07-19
Q2 2023 $6.21M -$6.52M -51.2% May 31, 2023 10-Q 2023-07-17
Q1 2023 $6.18M -$5.38M -46.5% Feb 28, 2023 10-Q 2023-05-26
Q4 2022 $12.6M -$3.09M -19.7% Nov 30, 2022 10-Q 2023-05-24
Q3 2022 $14.1M +$5.61M +66.3% Aug 31, 2022 10-K 2023-12-14
Q2 2022 $12.7M +$9.21M +261% May 31, 2022 10-Q 2022-07-14
Q1 2022 $11.6M +$7.9M +216% Feb 28, 2022 10-Q 2022-04-13
Q4 2021 $15.7M +$13.1M +503% Nov 30, 2021 10-Q 2022-01-18
Q3 2021 $8.46M +$5.86M +226% Aug 31, 2021 10-K 2023-04-03
Q2 2021 $3.52M +$994K +39.3% May 31, 2021 10-Q 2021-07-14
Q1 2021 $3.66M +$996K +37.4% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 $2.59M -$354K -12% Nov 30, 2020 10-Q 2021-01-13
Q3 2020 $2.6M -$428K -14.1% Aug 31, 2020 10-K 2021-12-14
Q2 2020 $2.53M -$2.05M -44.7% May 31, 2020 10-Q 2020-07-14
Q1 2020 $2.66M -$374K -12.3% Feb 29, 2020 10-Q 2020-04-20
Q4 2019 $2.95M -$391K -11.7% Nov 30, 2019 10-Q 2020-01-13
Q3 2019 $3.03M -$319K -9.53% Aug 31, 2019 10-K 2020-12-09
Q2 2019 $4.58M +$1.66M +56.7% May 31, 2019 10-Q 2019-07-11
Q1 2019 $3.04M -$27.6K -0.9% Feb 28, 2019 10-Q 2019-04-11
Q4 2018 $3.34M -$628K -15.8% Nov 30, 2018 10-Q 2019-01-11
Q3 2018 $3.35M -$928K -21.7% Aug 31, 2018 10-K 2019-11-20
Q2 2018 $2.92M -$6.64M -69.5% May 31, 2018 10-Q 2018-07-11
Q1 2018 $3.06M +$3.06M +58066% Feb 28, 2018 10-Q 2018-04-12
Q4 2017 $3.97M +$3.95M +20084% Nov 30, 2017 10-Q 2018-01-12
Q3 2017 $4.27M +$1.24M +41.1% Aug 31, 2017 10-K 2018-11-06
Q2 2017 $9.57M +$9.56M +101740% May 31, 2017 10-Q 2017-07-24
Q1 2017 $5.27K -$21.5K -80.4% Mar 31, 2017 10-Q 2017-04-14
Q4 2016 $19.7K +$6.54K +49.8% Dec 31, 2016 10-Q 2017-04-14
Q3 2016 $3.03M +$3.02M +25163% Sep 30, 2016 10-Q 2016-10-31
Q2 2016 $9.39K -$46.4K -83.2% Jun 30, 2016 10-Q 2016-07-22
Q1 2016 $26.8K -$74.4K -73.5% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $13.1K -$328K -96.1% Dec 31, 2015 10-K 2017-03-07
Q3 2015 $12K -$361K -96.8% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 $55.8K -$386K -87.4% Jun 30, 2015 10-Q 2015-07-31
Q1 2015 $101K -$290K -74.1% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 $341K -$217K -38.9% Dec 31, 2014 10-K 2016-03-25
Q3 2014 $373K +$166K +80.8% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $442K +$199K +81.7% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 $392K +$132K +50.7% Mar 31, 2014 10-Q 2014-05-19
Q4 2013 $558K +$316K +131% Dec 31, 2013 10-K 2015-03-27
Q3 2013 $206K -$7.94K -3.71% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 $243K +$69.8K +40.2% Jun 30, 2013 10-Q 2013-08-16
Q1 2013 $260K +$147K +130% Mar 31, 2013 10-Q 2013-05-20
Q4 2012 $242K +$100K +71.2% Dec 31, 2012 10-K 2014-04-16
Q3 2012 $214K +$73.5K +52.3% Sep 30, 2012 10-Q 2012-11-23
Q2 2012 $173K +$20.5K +13.4% Jun 30, 2012 10-Q/A 2012-09-13
Q1 2012 $113K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $141K -$941K -87% Dec 31, 2011 10-K 2013-04-15
Q3 2011 $141K Sep 30, 2011 10-Q 2011-11-21
Q2 2011 $153K Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $1.08M Dec 31, 2010 10-K 2012-04-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.